“It was first understood as our main defense against opioid overdose,” Nguyen said. “The issue is that for some time, the FDA had not granted the approval of over-the-counter, non-prescription use of Naloxone because I think the standards for treating opioid overdoses were still being developed.”
Trending
- Board of Regents approves nearly $1 billion operating budget, new AI-centered master’s degree
- Foster Pavilion to host rising country star Braxton Keith
- Dog days: Q&A with Wacoan that built hot dog social media brand
- Country legend Willie Nelson returns after 72 years for night of harmonies, hits
- Students react to ‘very stressful’ Canvas outage ahead of finals
- Canvas access to be restored, Friday finals moved to online Thursday
- Baylor delays finals as nationwide Canvas outage impedes studying
- SLIDESHOW: IM Claw Cup Championship

